Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
American Society of Hematology Logo Close
  • ASH Open Menu
    • ASH Home Open External Link
    • ASH Store Open External Link
    • Advocacy Open External Link
    • Education Open External Link
    • Meetings Open External Link
    • Publications Open External Link
    • Research Open External Link
  • ASH Clinical News
  • ASH Image Bank Open External Link
  • ASH News Daily
  • ASH-SAP
  • Blood Journals Open Menu
    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Immunology & Cellular Therapy
    • Blood Neoplasia
    • Blood Red Cells & Iron
    • Blood Vessels, Thrombosis & Hemostasis
  • Hematology
  • The Hematologist
  • International Open Menu
    • Blood Chinese Edition Open External Link
    • Blood Italian Edition Open External Link
    • Blood Latin America Edition Open External Link
    • Blood Spanish Edition Open External Link
Cart
User Tools Dropdown
Cart
Sign In Open Menu
Search Dropdown Menu
header search
    Search
    Blood
    Toggle MenuMenu
    • IssuesOpen Menu
      • Current Issue
      • All Issues
    • First edition
    • AbstractsOpen Menu
      • 2025 Annual Meeting
      • 2025 Late Breaking
      • 2024 Annual Meeting
      • 2024 Late Breaking
      • 2023 Annual Meeting
      • 2023 Late Breaking
      • 2022 Annual Meeting
      • 2022 Late Breaking
      • 2021 Annual Meeting
      • 2020 Annual Meeting
      • 2020 Late Breaking
      • All Meeting Abstracts
    • CollectionsOpen Menu
      • Blood Podcast
      • Blood Cover Contest
      • Maternal Health Compendium Second EditionOpen External Link
      • Maternal Health Compendium First EditionOpen External Link
      • Health Equity CompendiumOpen External Link
      • Blood 70th Anniversary CollectionOpen External Link
      • Multimedia
      • Article Type Collections
    • Author CenterOpen Menu
      • Alerts
      • Author Guide
      • Style Guide
      • SubmitOpen External Link
      • Why Submit to Blood?
    • AboutOpen Menu
      • About Blood
      • Alerts
      • Blood ClassifiedsOpen External Link
      • Copyright
      • Editorial Board
      • Publications StaffOpen External Link
      • Public Access
      • Subscriptions
    Skip Nav Destination

    Update search

    Querybuilder input 1
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 2
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 3
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 4
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 5
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 6
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI

    NARROW

    Publications

    Filter by publications

    Format

    Filter by format

    Article Type

    Filter by article-type

    Date

    Filter by date
    Apply

    Availability

    Availability
    1-2 of 2
    Jenna Wixom
    Close
    Save search
    Follow your search
    Access your saved searches in your account
    Would you like to receive an alert when new items match your search?
    Close Modal
    Sort by
    Journal Articles

    Interim PET-adapted de-escalation chemotherapy regimen for advanced stage classical Hodgkin lymphoma using brentuximab vedotin, pembrolizumab, doxorubicin, and dacarbazine: Phase 2 study

    Free
    Hun Lee, Gregory Ravizzini, Jenna Wixom, Ayushi Chauhan, Luis Fayad, Ranjit Nair, Jason Westin, Jared Henderson, Eslam Aboismail, Christopher Flowers, Michael Wang, Luis Malpica Castillo
    Journal: Blood
    Blood (2025) 146 (Supplement 1): 153.
    https://doi.org/10.1182/blood-2025-153
    Published: 2025
    Journal Articles

    Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

    Free
    Hun Ju Lee, Gregory Ravizzini, Eslam Aboismail, Jenna Wixom, Jared Henderson, Luis E. Fayad, Sairah Ahmed, Ranjit Nair, Jason R. Westin, Swaminathan P Iyer, Chijioke Nze, Ajlan Al Zaki, Francisco Vega, Michael Wang, Christopher R. Flowers, Luis Malpica
    Journal: Blood
    Blood (2024) 144 (Supplement 1): 1674.3.
    https://doi.org/10.1182/blood-2024-212005
    Published: 2024

    Advertisement intended for health care professionals

    Email alerts

    First Edition Alert
    Latest Issue Alert
    Close Modal

    Advertisement intended for health care professionals

    Blood
    • About Blood
    • Abstracts
    • Advertising in Blood
    • Alerts
    • All Issues
    • Author Guide
    • Blood Classifieds
    • Collections
    • Contact Us
    • Current Issue
    • First edition
    • Newsroom
    • Permissions
    • Subscriptions
    • Submit to Blood
    • American Society of Hematology
    • 2021 L Street NW, Suite 900
    • Washington, DC 20036
    • TEL +1 202-776-0544
    • FAX +1 202-776-0545
    American Society of Hematology

    ASH Publications

    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Immunology & Cellular Therapy
    • Blood Neoplasia
    • Blood Red Cells & Iron
    • Blood Vessels, Thrombosis & Hemostasis
    • Hematology, ASH Education Program
    • ASH Clinical News
    • ASH-SAP
    • The Hematologist

    American Society of Hematology

    • ASH Home
    • ASH Image Bank
    • ASH Store

    • Advocacy
    • Education
    • Meetings
    • Research
    Copyright 2025 by American Society of Hematology
     
    • Cookie Settings
    • Privacy Policy
    • Cookie Policy
    • Terms of Use
    • Contact Us
    Close Modal
    Close Modal
    This Feature Is Available To Subscribers Only

    Sign In or Create an Account

    Close Modal
    Close Modal

    Advertisement intended for health care professionals